Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod B Khedekar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chemmedchem|July 21, 2021
Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat TuberculosisMohit D Umare, Pramod B Khedekar, Rupesh V Chikhale
Pharmaceutical Methods|June 20, 2013
Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tabletsSeema M Dhole, Pramod B Khedekar, Nikhil D Amnerkar
Chemistry & Biodiversity|June 3, 2025
Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole-Conjugated Pyrazole DerivativesDeepali M Wanode, Pramod B Khedekar, Somdatta Y Chaudhari
International Journal of Biological Macromolecules|December 21, 2018
Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell lineNilesh R Rarokar, Pramod B Khedekar, Ashish P Bharne, et al.
Archives of Pharmacal Research|November 15, 2011
Isolation of phytosterols and antihyperlipidemic activity of Lagenaria sicerariaRavi P Kalsait, Pramod B Khedekar, Ashok N Saoji, et al.
Archiv Der Pharmazie|September 10, 2020
Development of novel indole-linked pyrazoles as anticonvulsant agents: A molecular hybridization approachDeweshri R Kerzare, Sunil S Menghani, Nilesh R Rarokar, et al.
Bioorganic Chemistry|August 15, 2021
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discoveryMayuri S Prasad, Ritesh P Bhole, Pramod B Khedekar, et al.
Npj Antimicrobials and Resistance|December 4, 2025
Evolution of proteolysis-targeting chimeras (PROTAC) technology to overcome challenges of antimicrobial resistanceDhanashree N Sarwan, Pramod B Khedekar, Ritesh P Bhole, et al.
Computers in Biology and Medicine|February 2, 2026
Molecular modelling assisted identification of novel Benzoxazole derivatives as hit molecules targeting Mycobacterial Membrane Protein Large 3 (MmpL3)Rupesh Chikhale, Vikramsinh Sardarsinh Suryawanshi, Shweta Sharma, et al.
Molecules (Basel, Switzerland)|October 28, 2023
A Review on Five and Six-Membered Heterocyclic Compounds Targeting the Penicillin-Binding Protein 2 (PBP2A) of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)Shraddha S Ambade, Vivek Kumar Gupta, Ritesh P Bhole, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chemmedchem|July 21, 2021
Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat TuberculosisMohit D Umare, Pramod B Khedekar, Rupesh V Chikhale
Pharmaceutical Methods|June 20, 2013
Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tabletsSeema M Dhole, Pramod B Khedekar, Nikhil D Amnerkar
Chemistry & Biodiversity|June 3, 2025
Synthesis, In Vitro Anticancer Activity, Molecular Docking, and Dynamic Simulation Study of Thiazole-Conjugated Pyrazole DerivativesDeepali M Wanode, Pramod B Khedekar, Somdatta Y Chaudhari
International Journal of Biological Macromolecules|December 21, 2018
Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell lineNilesh R Rarokar, Pramod B Khedekar, Ashish P Bharne, et al.
Archives of Pharmacal Research|November 15, 2011
Isolation of phytosterols and antihyperlipidemic activity of Lagenaria sicerariaRavi P Kalsait, Pramod B Khedekar, Ashok N Saoji, et al.
Archiv Der Pharmazie|September 10, 2020
Development of novel indole-linked pyrazoles as anticonvulsant agents: A molecular hybridization approachDeweshri R Kerzare, Sunil S Menghani, Nilesh R Rarokar, et al.
Bioorganic Chemistry|August 15, 2021
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discoveryMayuri S Prasad, Ritesh P Bhole, Pramod B Khedekar, et al.
Npj Antimicrobials and Resistance|December 4, 2025
Evolution of proteolysis-targeting chimeras (PROTAC) technology to overcome challenges of antimicrobial resistanceDhanashree N Sarwan, Pramod B Khedekar, Ritesh P Bhole, et al.
Computers in Biology and Medicine|February 2, 2026
Molecular modelling assisted identification of novel Benzoxazole derivatives as hit molecules targeting Mycobacterial Membrane Protein Large 3 (MmpL3)Rupesh Chikhale, Vikramsinh Sardarsinh Suryawanshi, Shweta Sharma, et al.
Molecules (Basel, Switzerland)|October 28, 2023
A Review on Five and Six-Membered Heterocyclic Compounds Targeting the Penicillin-Binding Protein 2 (PBP2A) of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)Shraddha S Ambade, Vivek Kumar Gupta, Ritesh P Bhole, et al.
Pageof 2